ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

31,628Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 1000

$1.37M Total Retail Price of All Prescriptions

Rank: 19 out of 1000

940 Patients Receiving at Least One Drug in Part D
59%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 940 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

40% of this provider’s 940 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

3% of this provider’s 19,109 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 2,629 1,030 S3 1 1
OMEPRAZOLE 975 641 2 2
LISINOPRIL 918 551 3 5
FUROSEMIDE 909 686 4 7
AMLODIPINE BESYLATE 905 672 5 6
SIMVASTATIN 900 604 6 3
METFORMIN HCL 756 434 7 8
GABAPENTIN 735 494 8 11
LOVASTATIN 535 365 9 41
TRAMADOL HCL 515 392 10 13
HYDROCHLOROTHIAZIDE 495 342 11 9
CEPHALEXIN 455 244 12 90
MELOXICAM 412 276 13 14
ZOLPIDEM TARTRATE 411 230 14 16
POTASSIUM CHLORIDE 403 348 15 10
PANTOPRAZOLE SODIUM 368 236 16 28
CARVEDILOL 352 234 17 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 346 254 18 20
CITALOPRAM HBR 336 177 19 17
NEXIUM 330 149 20 23
CARISOPRODOL 298 72 R 21 72
TRAZODONE HCL 298 131 21 29
GLIPIZIDE 283 166 23 62
METOPROLOL TARTRATE 279 175 24 19
FLUOXETINE HCL 277 165 25 51
WARFARIN SODIUM 268 228 26 22
LEVOTHYROXINE SODIUM 260 200 27 4
METOPROLOL SUCCINATE 259 148 28 21
CIPROFLOXACIN HCL 255 161 29 46
PREDNISONE 240 150 30 42
CLONIDINE HCL 226 147 31 27
ATENOLOL 222 188 32 24
LYRICA 210 67 33 47
FLUTICASONE PROPIONATE 210 80 33 40
PROAIR HFA 199 72 35 50
ALLOPURINOL 197 129 36 31
DONEPEZIL HCL 192 176 37 32
ATORVASTATIN CALCIUM 185 125 38 18
CYCLOBENZAPRINE HCL 182 50 R 39 39
CLOPIDOGREL 181 139 40 35
SERTRALINE HCL 176 104 41 26
RAMIPRIL 172 100 42 77
CRESTOR 169 112 43 30
MIRTAZAPINE 169 137 43 56
QUINAPRIL HCL 168 96 45 117
AMITRIPTYLINE HCL 164 98 R 46 45
LANTUS 155 104 47 68
DIGOXIN 153 133 48 52
PREMARIN 152 72 R 49 109
LOSARTAN POTASSIUM 152 134 49 25
SYNTHROID 147 83 51 91
PLAVIX 147 103 51 49
EXELON 141 124 53 108
ISOSORBIDE MONONITRATE ER 138 96 54 71
NAMENDA 138 138 54 43
PHENYTOIN SODIUM EXTENDED 133 61 56 115
PAROXETINE HCL 132 112 57 63
PROMETHAZINE HCL 130 49 R 58 54
TAMSULOSIN HCL 130 98 58 33
IBUPROFEN 124 61 60 94
PRAVASTATIN SODIUM 123 45 61 12
INSULIN SYRINGE 122 66 62 93
RANITIDINE HCL 121 85 63 37
ADVAIR DISKUS 114 69 64 65
BENAZEPRIL HCL 113 69 65 61
AMLODIPINE BESYLATE-BENAZEPRIL 113 61 65 59
TRIAMTERENE-HCTZ 113 92 65 48
AZITHROMYCIN 112 55 68 36
BUSPIRONE HCL 108 43 69 110
QUETIAPINE FUMARATE 108 72 69 75
ENALAPRIL MALEATE 107 72 71 58
LOSARTAN-HYDROCHLOROTHIAZIDE 107 51 71 38
MUPIROCIN 107 63 71 140
METFORMIN HCL ER 103 68 74 44
DILTIAZEM 24HR ER 102 93 75 189
FOSINOPRIL SODIUM 102 88 75 154
GLYBURIDE 101 34 R 77 92
CELEBREX 101 57 77 98
DICLOFENAC SODIUM 97 45 79 123
ENDOCET 96 29 S2 80 107
HALOPERIDOL 92 91 81 211
LEVOFLOXACIN 92 52 81 73
ACTOS 91 58 83 119
CYMBALTA 91 0 83 53
DIOVAN 90 66 85 67
SULFAMETHOXAZOLE-TRIMETHOPRIM 90 62 85 70
TIZANIDINE HCL 88 29 87 76
SINGULAIR 87 52 88 84
HUMULIN 70-30 84 49 89 131
SUMATRIPTAN SUCCINATE 82 12 90 282
NITROGLYCERIN PATCH 81 55 91 226
AMIODARONE HCL 81 66 91 178
MORPHINE SULFATE ER 79 47 S2 93 143
DIOVAN HCT 77 66 94 96
PROPRANOLOL HCL 76 52 95 135
ALENDRONATE SODIUM 75 55 96 57
ESTRADIOL 75 12 R 96 114
HYDRALAZINE HCL 75 50 96 74
FENTANYL 74 39 S2 99 100
GLIMEPIRIDE 73 66 100 34
CLOTRIMAZOLE-BETAMETHASONE 70 46 101 173
HYDROXYZINE HCL 70 38 R 101 153
VERAPAMIL ER 69 51 103 86
KLOR-CON M20 69 60 103 66
AGGRENOX 67 59 105 243
SPIRONOLACTONE 66 42 106 78
VENLAFAXINE HCL ER 66 0 106 124
THEOPHYLLINE ANHYDROUS 65 53 108 186
SPIRIVA 65 39 108 64
FAMOTIDINE 64 52 110 88
MECLIZINE HCL 64 62 110 80
METOCLOPRAMIDE HCL 63 16 112 99
DOXEPIN HCL 61 43 113 176
FENOFIBRATE 61 24 113 55
TOPIRAMATE 60 0 115 181
BACLOFEN 58 15 116 129
PIOGLITAZONE HCL 58 31 R 116 253
NITROFURANTOIN 58 39 116 199
RISPERIDONE 57 46 119 87
LATANOPROST 57 57 119 222
VENTOLIN HFA 54 12 121 83
FELODIPINE ER 54 34 121 210
SEROQUEL 53 41 123 157
COMBIVENT 51 25 124 193
ROPINIROLE HCL 51 14 124 82
GLIPIZIDE XL 51 29 124 138
ONDANSETRON HCL 50 21 127 204
NOVOLIN 70-30 50 31 127 160
FLUCONAZOLE 50 21 127 102
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.